Variant report

Variant	nsv1015149
Chromosome Location	chr9:1722601-1759811
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr9:1721060..1723569-chr9:1724371..1726152,2	MCF-7	breast:
2	chr9:1721060..1723569-chr9:1724371..1726152,2	MCF-7	breast:

Extended variants
information (count: 1577 )
Associated
traits (count: 103 )

Variant overlapped rSNPs/rCNVs (count:1577 , 50 per page) page: 1 2 3 4 5 6 7 ... 32

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs138076457	chr9:1722601-1722602	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs549793707	chr9:1722606-1722607	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs185403700	chr9:1722619-1722620	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs189265631	chr9:1722648-1722649	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs116258677	chr9:1722656-1722657	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs2783993	chr9:1722675-1722676	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs74911246	chr9:1722680-1722681	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs534914073	chr9:1722703-1722704	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs554857693	chr9:1722708-1722709	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs149467376	chr9:1722712-1722713	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs143866769	chr9:1722714-1722715	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs139890242	chr9:1722723-1722724	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs577131084	chr9:1722731-1722732	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs141639043	chr9:1722746-1722747	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs559915722	chr9:1722761-1722762	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs573359704	chr9:1722781-1722782	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs192573621	chr9:1722808-1722809	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs12338530	chr9:1722816-1722817	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs74427761	chr9:1722822-1722823	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs369829494	chr9:1722836-1722837	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs563310320	chr9:1722842-1722843	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs531951090	chr9:1722855-1722856	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs551731361	chr9:1722874-1722875	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs146200288	chr9:1722878-1722879	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs534412807	chr9:1722936-1722937	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs533707	chr9:1722942-1722943	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
27	rs568522301	chr9:1722943-1722944	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs537766151	chr9:1722973-1722974	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs375590812	chr9:1722980-1722981	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs527472646	chr9:1723019-1723020	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs543890099	chr9:1723021-1723022	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs370747049	chr9:1723035-1723036	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs577591522	chr9:1723072-1723073	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs539876911	chr9:1723113-1723114	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs79407535	chr9:1723114-1723115	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs573421638	chr9:1723140-1723141	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs541911715	chr9:1723145-1723146	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs561145741	chr9:1723157-1723158	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs75136004	chr9:1723161-1723162	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs543719994	chr9:1723172-1723173	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs139711872	chr9:1723175-1723176	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs183531445	chr9:1723182-1723183	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs377359233	chr9:1723190-1723191	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs371212621	chr9:1723191-1723192	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs374769629	chr9:1723202-1723203	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs188180944	chr9:1723208-1723209	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs10122632	chr9:1723244-1723245	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
48	rs78444932	chr9:1723286-1723287	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs547944447	chr9:1723328-1723329	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs10122657	chr9:1723337-1723338	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a

Variant related diseases (count:103)

Disease	PMID	Source
Ovarian cancer	21720365	CNVD
Myelofibrosis	22110671	CNVD
Lynch syndrome	18415027	CNVD
Retinoblastoma	21504564	CNVD
Melanoma	18172304	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Glioblastoma multiforme	22286061	CNVD
Williams-beuren syndrome	18553513	CNVD
Disorders of sex development	21048976	CNVD
Pilocytic astrocytoma	18622384	CNVD
Pilomyxoid astrocytoma	18622384	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
prenatal diagnosis	20453657	CNVD
Gastric cancer	16715143	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Intracranial aneurysm	16715129	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Disorders of sex development	22290220	CNVD
Glioblastoma multiforme	21080181	CNVD
Sudden cardiac death	19188705	CNVD
Non-small cell lung cancer	21829676	CNVD
Acute myeloid leukemia	16864856	CNVD
Cancer	21183584	CNVD
Non-small cell lung cancer	21952639	CNVD
Neuroblastoma	18923191	CNVD
Intellectual disability	22102821	CNVD
abnormal development	18461090	CNVD
Honadal dysgenesis	21048976	CNVD
Medulloblastoma	21979893	CNVD
Lung cancer	16740712	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Breast cancer	16608533	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	16272173	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Cervical cancer	21063398	CNVD
Retinoblastoma	22278416	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Biliary cancer	19435499	CNVD
Gastric cancer	21586687	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myopathy	18421352	CNVD
Neuroblastoma	18664255	CNVD
Acute lymphoblastic leukemia	18957548	CNVD
Myeloproliferative neoplasm	17564968	CNVD
Malignant meningioma	17937814	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Oligodendroglial tumors	17285580	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
microdeletion syndrome	16199537	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Cancer	20164919	CNVD
Chronic myeloid leukemia	21384125	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
small cell lung cancer	20016488	CNVD
Developmental delay	21147756	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Lung cancer	18438408	CNVD
Autism	20531469	CNVD
XY gonadal dysgenesis	20685758	CNVD
Urothelial carcinoma	21177765	CNVD
Oral cancer	21386901	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Myelodysplastic syndrome	21251322	CNVD
Breast cancer	21785460	CNVD
Prostate cancer	18632612	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21364760	CNVD
Breast cancer	21858162	CNVD
Renal cell carcinoma	21668985	CNVD
Autism	22495311	CNVD
Esophageal cancer	21851588	CNVD
Gastrointestinal stromal cancer	20877625	CNVD
Schizophrenia	23813976	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:51 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:1718000-1736800	Weak transcription	Adipose Nuclei	Adipose
2	chr9:1721600-1723400	Enhancers	Stomach Mucosa	stomach
3	chr9:1722400-1727200	Weak transcription	iPS-18 Cell Line	embryonic stem cell
4	chr9:1722600-1727400	Weak transcription	H1 Cell Line	embryonic stem cell
5	chr9:1723600-1724800	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
6	chr9:1724400-1725800	Weak transcription	HUES48 Cell Line	embryonic stem cell
7	chr9:1724800-1726600	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
8	chr9:1725600-1726600	Enhancers	iPS-15b Cell Line	embryonic stem cell
9	chr9:1725800-1726000	Enhancers	HUES48 Cell Line	embryonic stem cell
10	chr9:1726000-1726600	Enhancers	H9 Cell Line	embryonic stem cell
11	chr9:1726000-1727200	Weak transcription	HUES48 Cell Line	embryonic stem cell
12	chr9:1726600-1726800	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
13	chr9:1726600-1727000	Weak transcription	H9 Cell Line	embryonic stem cell
14	chr9:1726600-1727200	Weak transcription	iPS-15b Cell Line	embryonic stem cell
15	chr9:1727000-1727400	Enhancers	H9 Cell Line	embryonic stem cell
16	chr9:1727000-1727600	Enhancers	GM12878-XiMat	blood
17	chr9:1727200-1727400	Enhancers	iPS-15b Cell Line	embryonic stem cell
18	chr9:1727200-1727400	Enhancers	iPS-18 Cell Line	embryonic stem cell
19	chr9:1727200-1727600	Enhancers	HUES48 Cell Line	embryonic stem cell
20	chr9:1727400-1727600	Enhancers	H1 Cell Line	embryonic stem cell
21	chr9:1736800-1737000	Enhancers	Adipose Nuclei	Adipose
22	chr9:1737000-1738200	ZNF genes & repeats	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
23	chr9:1738000-1738200	ZNF genes & repeats	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
24	chr9:1738200-1738400	Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
25	chr9:1738200-1738800	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
26	chr9:1738400-1738600	Flanking Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
27	chr9:1738600-1739400	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
28	chr9:1739400-1739600	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
29	chr9:1739600-1740200	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
30	chr9:1740200-1740400	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
31	chr9:1740400-1741600	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
32	chr9:1742000-1742600	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
33	chr9:1742600-1745200	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
34	chr9:1743600-1744200	Enhancers	Fetal Brain Female	brain
35	chr9:1744000-1744400	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
36	chr9:1747600-1748000	ZNF genes & repeats	GM12878-XiMat	blood
37	chr9:1748000-1748400	Enhancers	GM12878-XiMat	blood
38	chr9:1757200-1757800	Enhancers	Fetal Muscle Leg	muscle
39	chr9:1757800-1759200	Weak transcription	Fetal Muscle Leg	muscle
40	chr9:1758600-1758800	ZNF genes & repeats	GM12878-XiMat	blood
41	chr9:1758800-1759000	Flanking Active TSS	GM12878-XiMat	blood
42	chr9:1759000-1759400	Enhancers	Ovary	ovary
43	chr9:1759000-1759800	Active TSS	GM12878-XiMat	blood
44	chr9:1759200-1759400	Enhancers	Fetal Muscle Trunk	muscle
45	chr9:1759200-1760000	Enhancers	Fetal Muscle Leg	muscle
46	chr9:1759200-1760400	Enhancers	HUES6 Cell Line	embryonic stem cell
47	chr9:1759200-1760400	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
48	chr9:1759400-1760000	Enhancers	ES-WA7 Cell Line	embryonic stem cell
49	chr9:1759600-1760200	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
50	chr9:1759800-1760400	Enhancers	iPS-18 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links